These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1380953)

  • 1. Restoration with phorbol ester of a locomotor defect in human leukaemic lymphocytes: a visual study of chronic lymphocytic leukaemia cells.
    Islam LN; Wilkinson PC
    Invasion Metastasis; 1992; 12(1):47-56. PubMed ID: 1380953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The defect of lymphocyte locomotion in chronic lymphocytic leukaemia: studies of polarization and growth-dependent locomotion.
    Wilkinson PC; Islam LN; Sinclair D; Dagg JH
    Clin Exp Immunol; 1988 Mar; 71(3):497-501. PubMed ID: 3383451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The locomotor capacity of human lymphocytes and its enhancement by cell growth.
    Wilkinson PC
    Immunology; 1986 Feb; 57(2):281-9. PubMed ID: 3081438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A inhibits mitogen-activated but not phorbol ester-activated locomotion of human lymphocytes.
    Wilkinson PC; Higgins A
    Immunology; 1987 Jul; 61(3):311-6. PubMed ID: 3610213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
    Engel P; Inglés J; de la Calle O; Gallart T
    Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes.
    Wilkinson PC; Watson EA
    Immunology; 1990 Nov; 71(3):417-22. PubMed ID: 1702750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant IL-4 and IFN-gamma activate locomotor capacity in human B lymphocytes.
    Wilkinson PC; Islam LN
    Immunology; 1989 Jun; 67(2):237-43. PubMed ID: 2502496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-stimulation of L-system amino acid transport in normal and chronic leukemic human lymphocytes: phorbol ester restores function in CLL.
    Segel GB; Woodlock TJ; Lichtman MA
    J Cell Physiol; 1988 Mar; 134(3):503-8. PubMed ID: 3258315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the human equilibrative nucleoside transporter1 (hENT1) activity by IL-4 and PMA in B cells from chronic lymphocytic leukemia.
    Fernández Calotti P; Galmarini CM; Cañones C; Gamberale R; Saénz D; Avalos JS; Chianelli M; Rosenstein R; Giordano M
    Biochem Pharmacol; 2008 Feb; 75(4):857-65. PubMed ID: 18078872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
    Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
    Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prohibitin expression is increased in phorbol ester-treated chronic leukemic B-lymphocytes.
    Woodlock TJ; Bethlendy G; Segel GB
    Blood Cells Mol Dis; 2001; 27(1):27-34. PubMed ID: 11162143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V; Gozzini A; Scappini B; Caporale R; Zoccolante A; Rigacci L; Gelardi E; Grossi A; Alterini R; Ferrini PR
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells.
    Visser L; Poppema S
    Br J Haematol; 1990 Jul; 75(3):359-65. PubMed ID: 2386770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of catalase on the proliferation of human lymphocytes to phorbol myristate acetate.
    Sagone AL; Husney R; Guter H; Clark L
    J Immunol; 1984 Sep; 133(3):1488-94. PubMed ID: 6747295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interleukin-6 and interleukin-12 blood levels in patients with chronic B-cell lymphocytic leukemia].
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Pol Merkur Lekarski; 2004 Feb; 16(92):157-61. PubMed ID: 15176301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.